Medication adherence issues in patients treated for COPD. - Wikidata - awgldk - TriplyDB

Medication adherence issues in patients treated for COPD.

Medication adherence issues in patients treated for COPD.

http://www.wikidata.org/entity/Q37070340

about

Reminder packaging for improving adherence to self-administered long-term medications COPD: adherence to therapy Psychosocial predictors of non-adherence to chronic medication: systematic review of longitudinal studies The association of weight with the detection of airflow obstruction and inhaled treatment among patients with a clinical diagnosis of COPD A psychological intervention to promote acceptance and adherence to non-invasive ventilation in people with chronic obstructive pulmonary disease: study protocol of a randomised controlled trial Efficacy of a multifactorial intervention on therapeutic adherence in patients with chronic obstructive pulmonary disease (COPD): a randomized controlled trial.Impact of Nonadherence to Inhaled Corticosteroid/LABA Therapy on COPD Exacerbation Rates and Healthcare Costs in a Commercially Insured US Population.Is it possible to diagnose the therapeutic adherence of patients with COPD in clinical practice? A cohort study.Ambulatory oxygen: why do COPD patients not use their portable systems as prescribed? A qualitative study.Factors related to good asthma control using different medical adherence scales in Latvian asthma patients: an observational study.Adjunctive treatment with oral AKL1, a botanical nutraceutical, in chronic obstructive pulmonary disease Implementation of GOLD consensus report in real life: results from the Velletri-Lariano (VELA) cohort.The role of fluticasone propionate/salmeterol combination therapy in preventing exacerbations of COPD.The adherence and illness perception of patients diagnosed with asthma or chronic obstructive pulmonary disease treated with polytherapy using new generation Cyclohaler.Vulnerability, beliefs, treatments and economic burden of chronic obstructive pulmonary disease in rural areas in China: a cross-sectional study.The combination of umeclidinium bromide and vilanterol in the management of chronic obstructive pulmonary disease: current evidence and future prospects.Improving adherence with inhaler therapy in COPD.Evaluation of patient preference and willingness to pay for attributes of maintenance medication for chronic obstructive pulmonary disease (COPD).Low use and adherence to maintenance medication in chronic obstructive pulmonary disease in the general population.Continuing to confront COPD International Surveys: comparison of patient and physician perceptions about COPD risk and management.Qualitative assessment of attributes and ease of use of the ELLIPTA™ dry powder inhaler for delivery of maintenance therapy for asthma and COPD.Delivery characteristics and patients' handling of two single-dose dry-powder inhalers used in COPD.Management of patients during and after exacerbations of chronic obstructive pulmonary disease: the role of primary care physicians.The role of galenic innovation in improving treatment compliance and persistence: three case studies.Patient-Centered Medical Home in chronic obstructive pulmonary disease Inhaler devices for chronic obstructive pulmonary disease: insights from patients and healthcare practitioners.Significance of Medication History at the Time of Entry into the COPDGene Study: Relationship with Exacerbation and CT Metrics.Predictors of adherence to inhaled medications among Veterans with COPD.Vulnerability of patients with chronic obstructive pulmonary disease according to gender in China.Optimizing safety of COPD treatments: role of the nurse practitioner.Effects of Educational Interventions for Chronic Airway Disease on Primary Care.The use of COPD maintenance therapy following spirometry in General Practice.Efficacy and safety of ipratropium bromide/salbutamol sulphate administered in a hydrofluoroalkane metered-dose inhaler for the treatment of COPD 'It is not going to change his life but it has picked him up': a qualitative study of perspectives on long term oxygen therapy for people with chronic obstructive pulmonary disease Assessment of satisfaction with different dry powder inhalation devices in Greek patients with COPD and asthma: the ANASA study.Correct usage, ease of use, and preference of two dry powder inhalers in patients with COPD: analysis of five phase III, randomized trials.Efficacy and safety of aclidinium bromide compared with placebo and tiotropium in patients with moderate-to-severe chronic obstructive pulmonary disease: results from a 6-week, randomized, controlled Phase IIIb study Association between depression and maintenance medication adherence among Medicare beneficiaries with chronic obstructive pulmonary disease.Asthma patients prefer Respimat Soft Mist Inhaler to Turbuhaler.Effectiveness of a pharmacist-driven intervention in COPD (EPIC): study protocol for a randomized controlled trial.

P2860

Q24234452-62706F94-4EA9-4094-8B77-B248A19AD65C Q27014720-B4D66B4A-644C-48CD-A4E3-4F83951FFCFC Q27022698-05A8B8FA-6370-4532-958F-1B4FE4E94863 Q27349146-7A8F4130-7BB1-4F9C-A811-74D47BD46230 Q29247950-A506480B-F263-491B-ADF2-0CE49C4E2C3C Q33573085-B193F4E9-E558-463A-986C-AA39616C5A40 Q33795984-6F7329F9-F79C-4197-A563-8BB8768426F2 Q33801644-5C5113FA-6641-43E5-96AD-94087F630AED Q33818711-ED44C45F-2BC5-42D9-BFE7-A94F1929DFBB Q33818917-B6459331-29DC-4640-9E16-74FE470829D7 Q33895428-DB41CD04-981C-41EE-A780-4C26CC1E358F Q33910793-BD587414-E304-4BFD-9B40-D1F43200BD0D Q33966009-7533DF7D-7837-4233-94E8-9E75164D4FE8 Q34227954-7FCE5359-8EF8-4738-8A5E-BE2EDD404EA0 Q34240886-730F87C2-8471-478B-9DF6-E57D14A67A97 Q34368537-B9903FFA-0031-4C87-B611-87FF63F14FB4 Q34432533-B746222B-4D56-4006-AF64-7FF8E2830AC3 Q34558862-AE8BA0CA-57B8-4DFC-9A06-0C0DF45C0B17 Q34826231-A04E7FA4-2E24-4E1C-AAB5-6D56D5DDBCD9 Q35026143-E8ECFAC1-4D5B-4661-A4B1-43A0D584886D Q35061912-62A64EAA-7D07-4715-8DE5-B318BC63F666 Q35096988-0DEDD8FF-31F8-4A9D-9F25-20CE30648031 Q35225129-3A8E6AB5-8D90-43B3-AB89-89A1A2A839E8 Q35454381-46E1CEC1-F17C-4914-A18F-764958BECFD2 Q35533465-974E2300-FC83-475B-BC0E-D39A063C794B Q36024374-101A66DF-348B-4D6B-AC00-5B32C03BA00A Q36207526-51F089FC-4089-43D0-83C0-574888990658 Q36331378-704D359E-29E4-4BFE-9A28-E74FD1B1F7AB Q36493552-CF4FA2A3-83BA-48CC-A0FE-BFC42CA6FC62 Q36642198-A933A85D-9E85-4392-BF9E-2F6F225DCBB9 Q36989774-78EE961B-DE3D-4198-917A-B6B8029D6EB0 Q37034234-2491855E-53F7-41DD-8BE7-EB723AF0A257 Q37069386-AB006A7D-B9A7-42E8-B048-52EDC08688D0 Q37113608-D0038E3A-E334-4993-898C-A1159E2F5F82 Q37167808-3F376DE2-C645-47A6-B010-FD59C892F924 Q37200540-FDC42E26-8299-408C-A04E-7F7D630B2710 Q37209291-B638824D-F725-4C6D-99C3-B47EF6B43F95 Q37230812-7AC03D28-FDDC-41B5-B535-CE83C34A1519 Q37236169-F0E8E5FB-63B5-41E2-9D98-E6DC42B08EE6 Q37340845-E12B1B3B-7089-4CB1-9A79-21F0CF89FC08

P2860

Medication adherence issues in patients treated for COPD.

http://www.wikidata.org/entity/Q37070340

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on January 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Medication adherence issues in patients treated for COPD.

@en

Medication adherence issues in patients treated for COPD.

@nl

type

label

Medication adherence issues in patients treated for COPD.

@en

Medication adherence issues in patients treated for COPD.

@nl

prefLabel

Medication adherence issues in patients treated for COPD.

@en

Medication adherence issues in patients treated for COPD.

@nl

P1433

Q37070340-0ED0CC3E-52B7-4766-8742-1DDA2B256776

P1476

Q37070340-F2BA7C3A-C258-4B58-8DF1-03F9648F20CA

P2093

Q37070340-4C7C787A-4715-434B-9FF6-103AA3984E1D

Q37070340-4DEF0A34-A46C-4D6B-9CC5-AACCF9B5249F

Q37070340-57B80791-E971-47FF-93A6-58EA9084859C

Q37070340-752E7122-7EF9-466D-ADB5-5AF6DDF435D3

Q37070340-77C27FBA-477B-443D-AFAA-72D3F8D3C8B5

Q37070340-9EA357A8-72A0-4032-9309-2FB34A80EC22

Q37070340-A0B7D882-BD99-418B-9E4B-FA78520F38FE

Q37070340-BE955E5D-60CB-4BE8-AF41-799540B7E5EE

Q37070340-DF253CE5-FD78-48CB-96C3-D42292C2E48A

P2860

Q37070340-01D43E8B-16E4-437B-978D-EDF30B487613

Q37070340-0AD2C347-635F-4078-9EA9-2FED71654686

Q37070340-0E2C2F69-5AE1-4DB5-9C25-04490227275C

Q37070340-1926EC60-356D-4C09-A249-B0F92AF4F434

Q37070340-1FE89B5D-AE41-46E9-9C2E-EBBEF5BEBA1E

Q37070340-21C8F961-7E8B-47E9-BB10-6BB54ADF678A

Q37070340-25406E75-4D04-4282-B38D-BC319FEB7387

Q37070340-28371789-CCFB-4A9D-99CB-5F653FBC7E77

Q37070340-2A5DFD0F-AA34-4FA8-A6D3-B345343E1EB1

Q37070340-301813F6-6797-4338-8314-DCD37949C40D

P304

Q37070340-E4466DB4-85E2-4423-B938-6B579F3576A7

P31

Q37070340-97ACC2AD-CCEE-4408-994E-EEDE36871CF6

P356

Q37070340-B6578CC5-1317-45D4-A1FE-96B5FAE526E6

P407

Q37070340-5670438B-F887-425B-85D1-E3F7411E097C

P433

Q37070340-8E87A8BA-64A3-4555-9949-050F889D37FE

P478

Q37070340-6AF364E6-08F7-4FB6-9DAA-BCD6B929DBAB

P577

Q37070340-6AB61633-2941-4FD9-81E5-A38962FE79B0

P698

Q37070340-C8272E23-29CD-48FA-A6ED-5AEAA069C82F

P921

Q37070340-A45BD13C-C35D-406B-A532-E2615DD2EA29

P932

Q37070340-73F6CBFA-C8A2-4F14-915C-AA1066F31FAD

P356

P1433

International Journal of Chronic Obstructive Pulmonary Disease

P1476

Medication adherence issues in patients treated for COPD.

@en

P2093

David L Vines

http://www.w3.org/2001/XMLSchema#string

Donna D Gardner

http://www.w3.org/2001/XMLSchema#string

Helen Sorenson

http://www.w3.org/2001/XMLSchema#string

Jennifer Sikkema-Ortiz

http://www.w3.org/2001/XMLSchema#string

Leonard D Wittnebel

http://www.w3.org/2001/XMLSchema#string

Melissa T Alvarez

http://www.w3.org/2001/XMLSchema#string

Richard Wettstein

http://www.w3.org/2001/XMLSchema#string

Robert L Wilkins

http://www.w3.org/2001/XMLSchema#string

Ruben D Restrepo

http://www.w3.org/2001/XMLSchema#string

P2860

Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease

Combined corticosteroid and long-acting beta-agonist in one inhaler versus inhaled steroids for chronic obstructive pulmonary disease

Combined corticosteroid and long-acting beta-agonist in one inhaler versus placebo for chronic obstructive pulmonary disease

Combined corticosteroid and long-acting beta-agonist in one inhaler versus long-acting beta-agonists for chronic obstructive pulmonary disease

Long-acting beta2-agonists for poorly reversible chronic obstructive pulmonary disease

Inhaled corticosteroids for stable chronic obstructive pulmonary disease

Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease

Impact of pharmaceutical underutilization: a study of insurance drug claims data.

Device selection and outcomes of aerosol therapy: Evidence-based guidelines: American College of Chest Physicians/American College of Asthma, Allergy, and Immunology.

Methods for measuring and monitoring medication regimen adherence in clinical trials and clinical practice.

P304

371-384

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/COPD.S3036

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P577

2008-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

18990964

http://www.w3.org/2001/XMLSchema#string

P921

P932

2629978

http://www.w3.org/2001/XMLSchema#string